Future of Health Care
Penn State Cancer Institute Researchers Promote Personalized Colorectal Cancer Screening in Central Pennsylvania
Colorectal cancer is the second-leading cause of cancer death in central Pennsylvania, which is partially attributable to low screening rates among certain segments of the population. Penn State Cancer Institute researchers are developing and testing strategies to improve screening rates in order to diagnose and treat colorectal cancer in earlier stages, when treatment efficacy is generally optimized.
True to its rich history of innovation, Penn State Heart and Vascular Institute at Penn State Health Milton S. Hershey Medical Center offers advanced therapies available only through clinical trials — treatments in the vanguard of care that can improve quality of life while laying the groundwork to help untold numbers of patients enjoy a brighter future.
Patients with a noninvasive, low-grade form of bladder cancer often need multiple surgeries to treat recurrences, which are common. A new chemoablative gel currently under study at Penn State Health may eliminate the need for those procedures.
Immersive 3D Technology Enhances Neurosurgical Outcomes at Penn State Health Milton S. Hershey Medical Center
A newly incorporated, cutting-edge visualization tool is improving the precision of brain and spinal surgeries at Penn State Health Milton S. Hershey Medical Center.
Educating a New Generation: The Milton S. Hershey Medical Center’s Innovative Neurosurgery Residency Training Program
The freshly expanded Neurosurgery Residency Training Program at Penn State Health Milton S. Hershey Medical Center offers world-class training, with the option for future neurosurgeons to complete their education at an accelerated pace.
It requires a remarkable confluence of factors to develop an innovative technology such as the minimally invasive rib fixation system invented by surgeons and other scientists at Penn State Health Milton S. Hershey Medical Center.
With its acquisition of Blue Light Cystoscopy with Cysview in December 2018, the urological team at Penn State Health Milton S. Hershey Medical Center is able to look into the bladder with pinpoint accuracy and immediately remove cancerous lesions that are invisible to the naked eye. More thorough eradication of tumors may reduce recurrence rates and the likelihood that missed cells will develop into more aggressive malignancies.
When two major movers in the region join together for improved health care and access, it’s a win-win for patients.
New Era of Radiosurgery Launches at Penn State Health Milton S. Hershey Medical Center: Installation of Gamma Knife Icon
As technologies and techniques have advanced in recent years, Gamma Knife radiosurgery has become a vital tool for enhancing outcomes among patients with brain tumors and other complex neurological disorders. Penn State Health Milton S. Hershey Medical Center recently reaffirmed its long-standing commitment to provide the most advanced care in the region by upgrading to the latest iteration of the Gamma Knife radiosurgery system: Leksell Gamma Knife®Icon™.
With a commitment to continually upgrading its capabilities to provide optimal patient care, Penn State Health Milton S. Hershey Medical Center has become a pioneer in the use of robotic technology for surgical procedures of the head and neck.
- 1 of 3
- next ›